Czech Republic: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in the Czech Republic

In 2021, the Czech medicaments containing corticosteroid hormones market increased by 3.8% to $X, rising for the second consecutive year after two years of decline. Over the period under review, consumption, however, saw a perceptible contraction. Over the period under review, the market hit record highs at $X in 2015; however, from 2016 to 2021, consumption remained at a lower figure.

Production of Medicaments Containing Corticosteroid Hormones in the Czech Republic

In value terms, medicaments containing corticosteroid hormones production plummeted to $X in 2021 estimated in export price. In general, production saw a pronounced contraction. The growth pace was the most rapid in 2017 with an increase of 119%. Over the period under review, production hit record highs at $X in 2015; however, from 2016 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from the Czech Republic

In 2021, overseas shipments of medicaments containing corticosteroid hormones were finally on the rise to reach X tons after two years of decline. In general, exports saw a remarkable increase. The most prominent rate of growth was recorded in 2013 with an increase of 72%. The exports peaked at X tons in 2018; however, from 2019 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing corticosteroid hormones exports soared to $X in 2021. Overall, exports enjoyed a resilient increase. The growth pace was the most rapid in 2014 when exports increased by 110%. Over the period under review, the exports hit record highs in 2021 and are likely to see steady growth in the near future.

Exports by Country

Germany (X tons), Russia (X tons) and Denmark (X tons) were the main destinations of medicaments containing corticosteroid hormones exports from the Czech Republic, together accounting for 54% of total exports. These countries were followed by Poland, Slovakia, the UK, the Netherlands, Belgium, Myanmar, France and Sweden, which together accounted for a further 33%.

From 2012 to 2021, the biggest increases were recorded for Belgium (with a CAGR of +142.2%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), Denmark ($X) and Slovakia ($X) constituted the largest markets for medicaments containing corticosteroid hormones exported from the Czech Republic worldwide, with a combined 69% share of total exports. Russia, the Netherlands, Poland, the UK, France, Sweden, Belgium and Myanmar lagged somewhat behind, together accounting for a further 16%.

In terms of the main countries of destination, Belgium, with a CAGR of +116.0%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average medicaments containing corticosteroid hormones export price stood at $X per ton in 2021, rising by 15% against the previous year. In general, export price indicated a tangible increase from 2012 to 2021: its price increased at an average annual rate of +4.7% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing corticosteroid hormones export price increased by +58.2% against 2017 indices. The most prominent rate of growth was recorded in 2014 when the average export price increased by 87%. As a result, the export price reached the peak level of $X per ton. From 2015 to 2021, the average export prices failed to regain momentum.

There were significant differences in the average prices for the major overseas markets. In 2021, the country with the highest price was Denmark ($X per ton), while the average price for exports to Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to France (+17.5%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into the Czech Republic

In 2021, the amount of medicaments containing corticosteroid hormones imported into the Czech Republic skyrocketed to X tons, growing by 17% on 2020 figures. In general, imports recorded prominent growth. The pace of growth was the most pronounced in 2014 when imports increased by 46%. Imports peaked at X tons in 2019; however, from 2020 to 2021, imports remained at a lower figure.

In value terms, medicaments containing corticosteroid hormones imports skyrocketed to $X in 2021. Overall, total imports indicated a strong increase from 2012 to 2021: its value increased at an average annual rate of +9.2% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +73.1% against 2016 indices. The pace of growth appeared the most rapid in 2014 when imports increased by 53%. Imports peaked in 2021 and are likely to see steady growth in the near future.

Imports by Country

In 2021, Germany (X tons) constituted the largest supplier of medicaments containing corticosteroid hormones to the Czech Republic, accounting for a 36% share of total imports. Moreover, medicaments containing corticosteroid hormones imports from Germany exceeded the figures recorded by the second-largest supplier, Denmark (X tons), fourfold. The third position in this ranking was taken by Italy (X tons), with a 7.4% share.

From 2012 to 2021, the average annual growth rate of volume from Germany amounted to +11.8%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (+20.3% per year) and Italy (+11.2% per year).

In value terms, the largest medicaments containing corticosteroid hormones suppliers to the Czech Republic were Denmark ($X), Germany ($X) and Belgium ($X), with a combined 47% share of total imports. These countries were followed by Italy, Slovakia, Poland, Hungary, Austria, France, the Netherlands, Spain, India and Portugal, which together accounted for a further 42%.

India, with a CAGR of +49.0%, recorded the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average medicaments containing corticosteroid hormones import price amounted to $X per ton, with an increase of 3.2% against the previous year. Over the period under review, the import price, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 when the average import price increased by 36% against the previous year. The import price peaked at $X per ton in 2014; however, from 2015 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably country of origin: the country with the highest price was Denmark ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Slovakia (+22.4%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :